Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report

J. Elinoff,R. Agarwal,C. Barnett,R. Benza,M. Cuttica,A. Gharib,Michael P. Gray,P. Hassoun,A. Hemnes,M. Humbert,T. Kolb,T. Lahm,J. Leopold,S. Mathai,V. McLaughlin,I. Preston,E. Rosenzweig,O. Shlobin,V. Steen,R. Zamanian,M. Solomon

Published 2018 in American Journal of Respiratory and Critical Care Medicine

ABSTRACT

The Critical Care Medicine Department of the National Institutes of Health Clinical Center and the Pulmonary Hypertension Association held a joint symposium to discuss "Challenges in Pulmonary Hypertension: Beating, Breathing, and Beyond." Communities of interest including patient advocates, clinicians, and academic investigators gathered together to raise awareness and highlight the challenges in diagnosing and treating pulmonary hypertension (PH). The current symposium focused on whether or not pulmonary arterial hypertension specific treatments are warranted as therapies for PH due to heart failure with preserved ejection fraction, interstitial lung disease, and pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis. While agreeing there is a need for treatments that can cross World Health Organization PH classifications, the symposium clearly pointed out that improved phenotyping is still needed to better determine who will benefit from these therapies.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 123 references · Page 1 of 2

CITED BY

Showing 1-21 of 21 citing papers · Page 1 of 1